Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 11 | 2018 | 1868 | 1.350 |
Why?
|
| Mothers | 5 | 2024 | 350 | 1.080 |
Why?
|
| Anti-HIV Agents | 4 | 2015 | 305 | 0.970 |
Why?
|
| Dried Blood Spot Testing | 2 | 2015 | 22 | 0.950 |
Why?
|
| Viral Load | 3 | 2015 | 382 | 0.940 |
Why?
|
| Drug Monitoring | 2 | 2015 | 158 | 0.910 |
Why?
|
| Malawi | 15 | 2019 | 389 | 0.830 |
Why?
|
| Prenatal Care | 3 | 2016 | 340 | 0.770 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2023 | 420 | 0.760 |
Why?
|
| Antiretroviral Therapy, Highly Active | 6 | 2015 | 265 | 0.720 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 826 | 0.720 |
Why?
|
| HIV-1 | 3 | 2015 | 465 | 0.700 |
Why?
|
| Health Care Costs | 2 | 2015 | 365 | 0.640 |
Why?
|
| Sexual Behavior | 2 | 2015 | 235 | 0.520 |
Why?
|
| RNA, Viral | 2 | 2015 | 540 | 0.510 |
Why?
|
| Schools, Medical | 1 | 2016 | 112 | 0.510 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 85 | 0.490 |
Why?
|
| Risk-Taking | 1 | 2015 | 93 | 0.490 |
Why?
|
| Reproductive Health | 1 | 2015 | 44 | 0.480 |
Why?
|
| Health Resources | 2 | 2015 | 116 | 0.480 |
Why?
|
| Abortion, Spontaneous | 3 | 2019 | 86 | 0.440 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2019 | 117 | 0.440 |
Why?
|
| Education, Medical | 1 | 2016 | 285 | 0.410 |
Why?
|
| Interviews as Topic | 4 | 2015 | 369 | 0.400 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2013 | 236 | 0.380 |
Why?
|
| Breast Feeding | 1 | 2013 | 220 | 0.380 |
Why?
|
| Sex Work | 1 | 2010 | 3 | 0.370 |
Why?
|
| Health Personnel | 1 | 2015 | 500 | 0.360 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 639 | 0.350 |
Why?
|
| Adult | 23 | 2024 | 29034 | 0.340 |
Why?
|
| Malaria | 2 | 2007 | 82 | 0.340 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 594 | 0.320 |
Why?
|
| Pregnancy | 15 | 2024 | 7137 | 0.320 |
Why?
|
| Pelvic Infection | 2 | 2019 | 6 | 0.320 |
Why?
|
| Motivation | 1 | 2010 | 314 | 0.300 |
Why?
|
| AIDS Serodiagnosis | 1 | 2008 | 56 | 0.300 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2013 | 443 | 0.300 |
Why?
|
| Doxycycline | 2 | 2019 | 117 | 0.300 |
Why?
|
| Metronidazole | 2 | 2019 | 155 | 0.300 |
Why?
|
| Poverty | 3 | 2024 | 420 | 0.290 |
Why?
|
| Data Collection | 3 | 2019 | 386 | 0.290 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2018 | 70 | 0.290 |
Why?
|
| Adolescent | 15 | 2023 | 19095 | 0.270 |
Why?
|
| Stress, Psychological | 3 | 2024 | 557 | 0.270 |
Why?
|
| Young Adult | 11 | 2024 | 8865 | 0.250 |
Why?
|
| Female | 24 | 2024 | 65444 | 0.240 |
Why?
|
| Qualitative Research | 4 | 2016 | 522 | 0.230 |
Why?
|
| Unsafe Sex | 2 | 2015 | 20 | 0.220 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 869 | 0.210 |
Why?
|
| Humans | 31 | 2024 | 123157 | 0.210 |
Why?
|
| Perception | 2 | 2015 | 221 | 0.210 |
Why?
|
| Health Surveys | 3 | 2015 | 241 | 0.210 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 113 | 0.210 |
Why?
|
| Rural Health | 2 | 2015 | 47 | 0.200 |
Why?
|
| Sex Offenses | 1 | 2023 | 48 | 0.200 |
Why?
|
| Social Support | 1 | 2024 | 344 | 0.200 |
Why?
|
| Pregnant Women | 1 | 2023 | 147 | 0.200 |
Why?
|
| Mental Health | 1 | 2024 | 349 | 0.180 |
Why?
|
| Students | 1 | 2023 | 253 | 0.180 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 334 | 0.170 |
Why?
|
| Chorioamnionitis | 1 | 2019 | 41 | 0.170 |
Why?
|
| Vesicovaginal Fistula | 1 | 2018 | 10 | 0.160 |
Why?
|
| Schistosoma haematobium | 1 | 2018 | 18 | 0.160 |
Why?
|
| Schistosomiasis haematobia | 1 | 2018 | 12 | 0.160 |
Why?
|
| Schistosomiasis | 1 | 2018 | 49 | 0.150 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2018 | 18 | 0.150 |
Why?
|
| Levonorgestrel | 1 | 2018 | 20 | 0.150 |
Why?
|
| Immunization | 1 | 2019 | 308 | 0.150 |
Why?
|
| Virus Shedding | 1 | 2018 | 79 | 0.150 |
Why?
|
| Contraceptive Agents, Female | 1 | 2018 | 29 | 0.150 |
Why?
|
| Cultural Characteristics | 2 | 2016 | 40 | 0.150 |
Why?
|
| Epidemiologic Methods | 1 | 2017 | 111 | 0.150 |
Why?
|
| Syringes | 1 | 2017 | 24 | 0.140 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 64 | 0.140 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2015 | 229 | 0.140 |
Why?
|
| Magnesium Sulfate | 1 | 2017 | 51 | 0.140 |
Why?
|
| HIV | 1 | 2018 | 179 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2019 | 305 | 0.140 |
Why?
|
| Middle Aged | 9 | 2018 | 25966 | 0.140 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 143 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2019 | 350 | 0.140 |
Why?
|
| Male | 10 | 2015 | 60040 | 0.140 |
Why?
|
| Social Stigma | 2 | 2016 | 72 | 0.130 |
Why?
|
| Workload | 2 | 2015 | 146 | 0.130 |
Why?
|
| Obstetric Surgical Procedures | 1 | 2016 | 2 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 2024 | 506 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 3380 | 0.130 |
Why?
|
| Diabetes, Gestational | 1 | 2017 | 109 | 0.130 |
Why?
|
| Cambodia | 1 | 2015 | 11 | 0.130 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 32 | 0.130 |
Why?
|
| Fistula | 1 | 2016 | 50 | 0.130 |
Why?
|
| Depression | 1 | 2024 | 1225 | 0.130 |
Why?
|
| Transients and Migrants | 1 | 2015 | 27 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2016 | 272 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2017 | 223 | 0.120 |
Why?
|
| Pakistan | 3 | 2019 | 77 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2016 | 384 | 0.120 |
Why?
|
| Phlebotomy | 1 | 2014 | 17 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1073 | 0.110 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 46 | 0.110 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 171 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 260 | 0.110 |
Why?
|
| Viremia | 1 | 2014 | 126 | 0.110 |
Why?
|
| Hospitalization | 1 | 2021 | 1733 | 0.110 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 3660 | 0.110 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 337 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2015 | 391 | 0.100 |
Why?
|
| Vaccination | 1 | 2017 | 950 | 0.100 |
Why?
|
| Spouses | 1 | 2013 | 66 | 0.100 |
Why?
|
| Focus Groups | 1 | 2013 | 200 | 0.100 |
Why?
|
| Infant | 5 | 2023 | 12339 | 0.090 |
Why?
|
| Hospitals | 1 | 2014 | 397 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2019 | 12116 | 0.090 |
Why?
|
| Rural Population | 1 | 2013 | 251 | 0.090 |
Why?
|
| Pleasure | 1 | 2010 | 12 | 0.090 |
Why?
|
| Double-Blind Method | 3 | 2019 | 1588 | 0.090 |
Why?
|
| Condoms | 1 | 2010 | 48 | 0.090 |
Why?
|
| Culture | 1 | 2010 | 67 | 0.090 |
Why?
|
| Drug Utilization | 1 | 2011 | 158 | 0.090 |
Why?
|
| Job Satisfaction | 1 | 2010 | 78 | 0.090 |
Why?
|
| Developing Countries | 3 | 2019 | 270 | 0.090 |
Why?
|
| Income | 1 | 2010 | 133 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 462 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2024 | 0.080 |
Why?
|
| Tanzania | 2 | 2019 | 66 | 0.080 |
Why?
|
| Uganda | 2 | 2019 | 70 | 0.080 |
Why?
|
| Marital Status | 1 | 2008 | 34 | 0.080 |
Why?
|
| Time Factors | 2 | 2018 | 6204 | 0.080 |
Why?
|
| Violence | 1 | 2009 | 114 | 0.080 |
Why?
|
| Crime Victims | 1 | 2009 | 59 | 0.080 |
Why?
|
| Public Health Administration | 1 | 2007 | 8 | 0.070 |
Why?
|
| Public Health Practice | 1 | 2007 | 21 | 0.070 |
Why?
|
| National Health Programs | 1 | 2007 | 21 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 402 | 0.070 |
Why?
|
| Endemic Diseases | 1 | 2007 | 58 | 0.070 |
Why?
|
| Africa, Southern | 1 | 2007 | 7 | 0.070 |
Why?
|
| Social Class | 1 | 2008 | 192 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 400 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3011 | 0.070 |
Why?
|
| Circumcision, Male | 1 | 2007 | 25 | 0.070 |
Why?
|
| Aggression | 1 | 2009 | 226 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2397 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2019 | 671 | 0.070 |
Why?
|
| Child | 3 | 2023 | 24225 | 0.060 |
Why?
|
| Social Marginalization | 1 | 2024 | 1 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 260 | 0.060 |
Why?
|
| Medication Adherence | 2 | 2023 | 388 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 6028 | 0.060 |
Why?
|
| Chloroquine | 1 | 1984 | 32 | 0.060 |
Why?
|
| Africa South of the Sahara | 2 | 2019 | 121 | 0.060 |
Why?
|
| Aged | 4 | 2021 | 19067 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 1255 | 0.050 |
Why?
|
| Student Health Services | 1 | 2023 | 3 | 0.050 |
Why?
|
| Universities | 1 | 2023 | 126 | 0.050 |
Why?
|
| Risk Factors | 3 | 2023 | 10010 | 0.050 |
Why?
|
| Law Enforcement | 1 | 2021 | 17 | 0.050 |
Why?
|
| Prevalence | 3 | 2018 | 2405 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2011 | 8103 | 0.050 |
Why?
|
| Incidence | 1 | 2007 | 3049 | 0.040 |
Why?
|
| Urinalysis | 1 | 2018 | 62 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 1243 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2018 | 51 | 0.040 |
Why?
|
| Microscopy | 1 | 2018 | 118 | 0.040 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 96 | 0.040 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 135 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 501 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6373 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 730 | 0.030 |
Why?
|
| Vaginal Fistula | 1 | 2016 | 3 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1105 | 0.030 |
Why?
|
| Urinary Incontinence | 1 | 2016 | 69 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 819 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 527 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1070 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1387 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1259 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2007 | 13880 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2011 | 213 | 0.020 |
Why?
|
| Philippines | 1 | 2009 | 23 | 0.020 |
Why?
|
| Schools | 1 | 2009 | 222 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2007 | 172 | 0.020 |
Why?
|
| United States | 1 | 2021 | 10629 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1932 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2007 | 449 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1984 | 193 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 1984 | 64 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 3329 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 33723 | 0.010 |
Why?
|